Incyte
INCY
#1188
Rank
C$27.56 B
Marketcap
C$138.52
Share price
-0.40%
Change (1 day)
31.70%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): C$8.54

According to Incyte's latest financial reports the company's current EPS (TTM) is C$8.37. In 2024 the company made an earnings per share (EPS) of C$0.42 a decrease over its 2023 EPS that were of C$3.65.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$8.541914.32%
2024C$0.42-88.39%
2023C$3.6573.38%
2022C$2.11-64.1%
2021C$5.87-408.63%
2020C-$1.90-166.83%
2019C$2.84300%
2018C$0.71-133.33%
2017C-$2.13-378.57%
2016C$0.772700%
2015C$0.02734-106.67%
2014C-$0.41-44.44%
2013C-$0.7450%
2012C-$0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$10.06 20.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.47 276.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.59 134.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.27-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.16-101.96%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C-$0.79-109.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.15-113.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C-$0.31-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA